UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 479

Sortiert nach

Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans

Nutrients, 2019-05, Vol.11 (6), p.1234

2019

Link zum Volltext

Verfügbarkeit prüfen

Beyond DNA Repair: Additional Functions of PARP-1 in Cancer

Frontiers in oncology, 2013-11, Vol.3, p.290

2013

Link zum Volltext

Verfügbarkeit prüfen

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

Journal of clinical oncology, 2020-12, Vol.38 (36), p.4274-4282

2020

Link zum Volltext

Verfügbarkeit prüfen

Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells

PloS one, 2012-10, Vol.7 (10), p.e46614

2012

Link zum Volltext

Verfügbarkeit prüfen

Current and Emerging Clinical Applications of Multispectral Optoacoustic Tomography (MSOT) in Oncology

Clinical cancer research, 2016-07, Vol.22 (14), p.3432-3439

2016

Link zum Volltext

Verfügbarkeit prüfen

Combined Targeting of Mutant p53 and Jumonji Family Histone Demethylase Augments Therapeutic Efficacy of Radiation in H3K27M DIPG

International journal of molecular sciences, 2020-01, Vol.21 (2), p.490

2020

Link zum Volltext

Verfügbarkeit prüfen

18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition

Clinical cancer research, 2022-01, Vol.28 (2), p.327-337

2022

Link zum Volltext

Verfügbarkeit prüfen

Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast Cancer

Frontiers in oncology, 2021-09, Vol.11, p.703802-703802

2021

Link zum Volltext

Verfügbarkeit prüfen

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer

Breast cancer research : BCR, 2021-03, Vol.23 (1), p.30-12, Article 30

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer

Breast cancer research and treatment, 2023-04, Vol.198 (2), p.217-229

2023

Link zum Volltext

Verfügbarkeit prüfen

Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling

Nature communications, 2022-08, Vol.13 (1), p.5013-17, Article 5013

2022

Link zum Volltext

Verfügbarkeit prüfen

PARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis?

Cancers, 2013-07, Vol.5 (3), p.943-958

2013

Link zum Volltext

Verfügbarkeit prüfen

The Impact of DNA Repair Pathways in Cancer Biology and Therapy

Cancers, 2017-09, Vol.9 (9), p.126

2017

Link zum Volltext

Verfügbarkeit prüfen

Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer

PloS one, 2020-02, Vol.15 (2), p.e0229077-e0229077

2020

Link zum Volltext

Verfügbarkeit prüfen

Implementation and utilization of the molecular tumor board to guide precision medicine

Oncotarget, 2017-08, Vol.8 (34), p.57845-57854

2017

Link zum Volltext

Verfügbarkeit prüfen

The antitumor effects of entinostat in ovarian cancer require adaptive immunity

Cancer, 2018-12, Vol.124 (24), p.4657-4666

2018

Link zum Volltext

Verfügbarkeit prüfen

HER2 Overexpression Renders Human Breast Cancers Sensitive to PARP Inhibition Independently of Any Defect in Homologous Recombination DNA Repair

Cancer research (Chicago, Ill.), 2012-09, Vol.72 (18), p.4796-4806

2012

Link zum Volltext

Verfügbarkeit prüfen

Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells

Cancer research (Chicago, Ill.), 2008-11, Vol.68 (22), p.9141-9146

2008

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors

Journal of Immunotherapy and Precision Oncology, 2023-02, Vol.6 (1), p.31-49

2023

Link zum Volltext

Verfügbarkeit prüfen

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

Molecular cancer research, 2018-05, Vol.16 (5), p.813-824

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer

Cancers, 2021-07, Vol.13 (15), p.3749

2021

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab augments cytotoxicity with poly (adp-ribose) polymerase inhibition in head and neck cancer

PloS one, 2011-08, Vol.6 (8), p.e24148

2011

Link zum Volltext

Verfügbarkeit prüfen

JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma

Molecular cancer therapeutics, 2018-01, Vol.17 (1), p.107-118

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of manual and automatic segmentation methods for brain structures in the presence of space-occupying lesions: a multi-expert study

Physics in medicine & biology, 2011-07, Vol.56 (14), p.4557-4577

2011

Link zum Volltext

Verfügbarkeit prüfen

The BET Inhibitor JQ1 Potentiates the Anticlonogenic Effect of Radiation in Pancreatic Cancer Cells

Frontiers in oncology, 2022-06, Vol.12, p.925718

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 479

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(429)
Mit Volltextzugriff
(451)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(308)
Life Sciences & Biomedicine
(217)
Humans
(150)
Oncology
(94)
Female
(69)
Physical Sciences
(64)
Male
(63)
Technology
(60)
Animals
(55)
Tumors
(42)
Science & Technology - Other Topics
(40)
Middle Aged
(38)
Environmental Sciences & Ecology
(37)
Engineering
(36)
Environmental Sciences
(36)
Physics
(36)
Gene Expression
(35)
Physics, Applied
(32)
Mice
(31)
Cancer
(29)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans

Beyond DNA Repair: Additional Functions of PARP-1 in Cancer

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells

Current and Emerging Clinical Applications of Multispectral Optoacoustic Tomography (MSOT) in Oncology

Combined Targeting of Mutant p53 and Jumonji Family Histone Demethylase Augments Therapeutic Efficacy of Radiation in H3K27M DIPG

18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition

Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast Cancer

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer

A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer

Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling

PARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis?

The Impact of DNA Repair Pathways in Cancer Biology and Therapy

Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer

Implementation and utilization of the molecular tumor board to guide precision medicine

The antitumor effects of entinostat in ovarian cancer require adaptive immunity

HER2 Overexpression Renders Human Breast Cancers Sensitive to PARP Inhibition Independently of Any Defect in Homologous Recombination DNA Repair

Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells

Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer

Cetuximab augments cytotoxicity with poly (adp-ribose) polymerase inhibition in head and neck cancer

JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma

Comparison of manual and automatic segmentation methods for brain structures in the presence of space-occupying lesions: a multi-expert study

The BET Inhibitor JQ1 Potentiates the Anticlonogenic Effect of Radiation in Pancreatic Cancer Cells

Suchergebnisse filtern